Earnings Summary

Insmed Incorporated’s revenue jumped 18.41% since last year same period to $77.23Mn in the Q2 2023. On a quarterly growth basis, Insmed Incorporated has generated 18.42% jump in its revenue since last 3-months.

Insmed Incorporated’s net profit fell -155.96% since last year same period to $-244.81Mn in the Q2 2023. On a quarterly growth basis, Insmed Incorporated has generated -53.23% fall in its net profits since last 3-months.

Insmed Incorporated’s net profit margin fell -116.16% since last year same period to -316.99% in the Q2 2023. On a quarterly growth basis, Insmed Incorporated has generated -29.39% fall in its net profit margins since last 3-months.

Insmed Incorporated’s earning per share (EPS) estimates for the current quarter stand at -1 - a -12.36% fall from last quarter’s estimates.

Insmed Incorporated’s earning per share (EPS) estimates for the current year stand at -1.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Insmed Incorporated’s return on assets (ROA) stands at -0.33.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Insmed Incorporated’s return on equity (ROE) stands at -14.53.